Prognosis for patients with thin cutaneous melanoma

Estimates of long‐term survival for patients with thin (≤ 1 mm) primary cutaneous melanomas vary widely. Two separate methods were used to study the survival of patients with melanoma from New South Wales (NSW), Australia, and from the Sydney Melanoma Unit (SMU).

[1]  S. George,et al.  The long‐term clinical course of patients with cutaneous melanoma , 2002, Cancer.

[2]  J. Kirkwood,et al.  Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  D L Morton,et al.  Multivariate analysis of the relationship between survival and the microstage of primary melanoma by clark level and breslow thickness , 1993, Cancer.

[4]  Yuting Zhang,et al.  Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma , 2003, Cancer.

[5]  K. Jöckel,et al.  Skin melanoma in Saarland: incidence, survival and mortality 1970–1996 , 2001, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[6]  Martin F. Mihm,et al.  Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  M. Berwick,et al.  Predicting five‐year outcome for patients with cutaneous melanoma in a population‐based study , 1996, Cancer.

[8]  N. Cascinelli,et al.  Stage I melanoma of the skin: Evaluation of prognosis according to histologic characteristics , 1981, Cancer.

[9]  R. MacKie,et al.  Prognostic models for subgroups of melanoma patients from the Scottish Melanoma Group database 1979-86, and their subsequent validation. , 1995, British Journal of Cancer.

[10]  U. Ringborg,et al.  Prognostic factors in thin cutaneous malignant melanoma , 1994, Cancer.

[11]  P. Carli,et al.  Skin melanoma in Italy: a population-based study on survival and prognostic factors. , 1998, European journal of cancer.

[12]  H. Olsson,et al.  Prognostic factors in invasive cutaneous malignant melanoma: a population-based study and review , 2001, Melanoma research.

[13]  C. Garbe,et al.  Author reply to previously published correspondence , 2002, Cancer.

[14]  F. Meyskens,et al.  Cutaneous malignant melanoma (arizona cancer center experience). I. Natural history and prognostic factors influencing survival in patients with stage i disease , 1988, Cancer.

[15]  L. Karnell,et al.  The National Cancer Data Base report on cutaneous and noncutaneous melanoma , 1998, Cancer.

[16]  C. Garbe,et al.  Primary cutaneous melanoma. Optimized cutoff points of tumor thickness and importance of clark's level for prognostic classification , 1995, Cancer.

[17]  D. Reintgen,et al.  Lethal “Thin” Malignant Melanoma: Identifying Patients at Risk , 1988, Annals of surgery.

[18]  R. MacKie,et al.  The relationship between risk of death from clinical stage 1 cutaneous melanoma and thickness of primary tumour: no evidence for steps in risk. Scottish Melanoma Group. , 1991, British Journal of Cancer.

[19]  D L Morton,et al.  Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. , 1999, Annals of surgery.

[20]  A. Sober,et al.  Ultra‐late recurrence (15 years or longer) of cutaneous melanoma , 1997, Cancer.

[21]  C. Karakousis,et al.  Tumor thickness and prognosis in clinical stage I malignant melanoma , 1989, Cancer.

[22]  A. Halpern,et al.  A Prognostic Model for Predicting 10-Year Survival in Patients with Primary Melanoma , 1996, Annals of Internal Medicine.

[23]  J. Thompson,et al.  Cutaneous melanomas that defy conventional prognostic indicators. , 1996, Seminars in oncology.

[24]  N Cascinelli,et al.  Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  S. McCarthy,et al.  Thin malignant melanomas and recurrence potential. , 1987, Archives of surgery.

[26]  J Sunil Rao,et al.  A long-term analysis of 1018 patients with melanoma by classic Cox regression and tree-structured survival analysis at a major referral center: Implications on the future of cancer staging. , 2002, Surgery.

[27]  Raymond L. Barnhill,et al.  Long-Term Results of a Prospective Surgical Trial Comparing 2 cm vs. 4 cm Excision Margins for 740 Patients With 1–4 mm Melanomas , 2001, Annals of Surgical Oncology.

[28]  C. Holman,et al.  Survival among patients with clinical stage i cutaneous malignant melanoma diagnosed in Western Australia in 1975/1976 and 1980/1981 , 1991, Cancer.